Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

Abstract The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance heal...

Full description

Bibliographic Details
Main Authors:	Paolo Martelletti, Matilde Leonardi, Messoud Ashina, Rami Burstein, Soo-Jin Cho, Augustina Charway-Felli, David W. Dodick, Raquel Gil-Gouveia, Licia Grazzi, Christian Lampl, Antoinette MaassenVanDenBrink, Mia T. Minen, Dimos Dimitrios Mitsikostas, Jes Olesen, Mayowa Ojo Owolabi, Uwe Reuter, Elena Ruiz de la Torre, Simona Sacco, Todd J Schwedt, Gianluca Serafini, Nirmal Surya, Cristina Tassorelli, Shuu-Jiun Wang, Yonggang Wang, Tissa Wijeratne, Alberto Raggi
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Series:	The Journal of Headache and Pain
Subjects:	Migraine Medication overuse headache Tension-type headache Sustainable development goals Global burden of disease study Low- and middle-income countries
Online Access:	https://doi.org/10.1186/s10194-023-01666-2

Similar Items

A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
by: Srdjan Ljubisavljevic, et al.
Published: (2023-10-01)

Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
by: Todd J. Schwedt, et al.
Published: (2018-05-01)

Medication overuse headache: a review of current evidence and management strategies
by: Yabets Tesfaye Kebede, et al.
Published: (2023-08-01)

Pharmacotherapy of the most frequent headaches in adults
by: Zidverc-Trajković Jasna
Published: (2019-01-01)

The burden attributable to primary headache disorders in children and adolescents in Ethiopia: estimates from a national schools-based study
by: Yared Zenebe Zewde, et al.
Published: (2024-04-01)

The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study
by: Nfwama Kawatu, et al.
Published: (2022-09-01)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
by: Hans-Christoph Diener, et al.
Published: (2022-08-01)

Clinical Utility of Leeds Dependence Questionnaire in Medication-Overuse Headache
by: Yen-Feng Wang, et al.
Published: (2023-01-01)

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01)

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins
by: Sara M. Schaefer, et al.
Published: (2015-07-01)

Role of educational programs in management of patients with medication-overuse headache
by: A. E. Shagbazyan, et al.
Published: (2021-06-01)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
by: Simona Guerzoni, et al.
Published: (2023-06-01)

Evaluation and treatment of medication-overuse headache: Russian experts’ guidelines
by: G. R. Tabeeva, et al.
Published: (2022-02-01)

Secondary headaches - red and green flags and their significance for diagnostics
by: Tissa Wijeratne, et al.
Published: (2023-09-01)

The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders
by: Matilde Leonardi, et al.
Published: (2024-01-01)

Theory of mind in chronic migraine with medication overuse assessed with the MASC
by: Sara Bottiroli, et al.
Published: (2024-03-01)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
by: Jacob Genizi, et al.
Published: (2023-09-01)

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
by: Nicole Limberg
Published: (2023-06-01)

Medication Overuse Headache: How Much Are We Aware?
by: Özlem Ethemoğlu, et al.
Published: (2021-06-01)

Transcranial Direct Current Stimulation and Migraine—The Beginning of a Long Journey
by: Samar S. Ayache, et al.
Published: (2020-04-01)

Medication-overuse headache—a review of different treatment strategies
by: Abouch Krymchantowski, et al.
Published: (2023-10-01)

Severe drug-induced headache with its possible recurrent statuses in a patient with chronic tension headache
by: V. V. Osipova, et al.
Published: (2020-08-01)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine
by: Ioana Ion, et al.
Published: (2018-06-01)

A Single-Group Study on the Effect of OnabotulinumtoxinA in Patients with Chronic Migraine Associated with Medication Overuse Headache: Pain Catastrophizing Plays a Role
by: Licia Grazzi, et al.
Published: (2023-01-01)

Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study)
by: Licia Grazzi, et al.
Published: (2023-07-01)

Narrative-based medicine in headache disorders
by: Christian Lampl, et al.
Published: (2022-06-01)

Headache Attributed to Reversible Cerebral Vasoconstriction Syndrome (RCVS)
by: Vasileios Tentolouris-Piperas, et al.
Published: (2023-08-01)

Social cognition in chronic migraine with medication overuse: a cross-sectional study on different aspects of mentalization and social relationships
by: Sara Bottiroli, et al.
Published: (2023-04-01)

Sex differences in the clinical manifestations related to dependence behaviors in medication-overuse headache
by: Yen-Feng Wang, et al.
Published: (2023-11-01)

Treatment Patterns for and Characteristics of Headache in Children and Adolescents Aged 6–17 Years in Japan: A Retrospective Cross-Sectional and Longitudinal Analysis of Health Insurance Claims Data
by: Masahito Katsuki, et al.
Published: (2024-01-01)

Factors Associated with Over-the-Counter Analgesic Overuse among Individuals Experiencing Headache
by: Maram Alshareef
Published: (2022-09-01)

Role of Endo-opioid and Endo-cannabinoid Systems in Migraine and Medication-overuse Headache
by: Gökçen Hatipoğlu, et al.
Published: (2022-12-01)

Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study
by: Christina Deligianni, et al.
Published: (2023-04-01)

COVID-19 vaccination-related headache showed two different clusters in the long-term course: a prospective multicenter follow-up study (COVA-Head Study)
by: Arife Çimen Atalar, et al.
Published: (2023-09-01)

Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly’s Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City—Itoigawa Hisui Study
by: Masahito Katsuki, et al.
Published: (2022-08-01)

New daily persistent headache: a systematic review on an enigmatic disorder
by: Nooshin Yamani, et al.
Published: (2019-07-01)

Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluation
by: María Pilar Navarro-Pérez, et al.
Published: (2022-10-01)

Imaging the brain and vascular reactions to headache treatments: a systematic review
by: R. Messina, et al.
Published: (2023-05-01)

Effects of PDE-3 inhibition in persistent post-traumatic headache: evidence of cAMP-dependent signaling
by: Haidar M. Al-Khazali, et al.
Published: (2024-04-01)

Adding eptinezumab to brief patient education to treat chronic migraine and medication-overuse headache: Protocol for RESOLUTION—A phase 4, multinational, randomized, double-blind, placebo-controlled study
by: Rigmor H. Jensen, et al.
Published: (2023-02-01)